New idea of drug bidding -- encourage "report"!

Wen Kusi sweeping monk The latest drug bidding new ideas, old-fashioned way, but the effect is obvious, this method is to encourage "reporting"! Recently, there are two drug procurement projects, especially the price publicity, welcome to apply for complaints from all walks of life! According to the notice on the confirmation and publicity of information enterprises related to the sale of drugs (including drugs in the national drug catalog of Tianjin 2019 version) by designated medical institutions of Tianjin medical security, the online publicity of drug information is especially emphasized During the publicity period, if there is any objection to the publicity content, according to the principle of "who claims, who provides evidence", the relevant enterprises can fill in the drug price information to other enterprises Apply for review and operate in the system After the end of the publicity period, the application for review will not be accepted Enterprises that maliciously apply for review are deemed to have dishonesty and included in the credit records of enterprises The drugs questioned during the publicity period shall be verified before participating in the follow-up work 。 According to the relevant requirements of drug price linkage in Jiangsu Province, relevant price information is publicized to all sectors of the society During the publicity period, you are also welcome to apply for complaints! All of this is due to the reform carried out by the drug centralized procurement platforms in various regions to highlight sunshine, transparency, fairness and openness after the collapse of centralized drug bidding and procurement From 2016 to now, no matter the price limit announcement, product shortlist announcement, or price dynamic adjustment, several big provinces of drug procurement have made the same sincere "banner": if there is any objection, welcome to appeal! (the implication is welcome to report.) So, for a while, the pharmaceutical bidding business community was excited and spirited In order to report others and not be reported by others, countless bidding gentlemen turned into Ding Xiaojia and Xue Jiaqiang in the apostle Through data comparison and competitive product analysis, along the tusoji, a bloody battle of tearing force was launched, which inspired the bidding gentleman to learn from the rising sun people ——There is a problem with the difference ratio of this competitive product Please upload the explanation immediately, stamp it and do it! ——Our competitive price is not the lowest in China? On the platform, complain about them! ——Such a high price is waiting for me to report In the eyes of the sunrise people in the field of medicine recruitment, at this moment, they have already killed their eyes They all agree that no one really depends on morality to make a living Lao Tzu's Tao Te Ching has been published for more than 2000 years, and no royalty has been paid So, what's your price Under the guidance of this kind of thought, a letter of application and complaint is uploaded on the platform, and a big show of shirtless fighting begins According to the rumor, the price linkage in Tianjin has mastered the price procurement data of Fujian Province and prefecture level cities of Zhejiang provincial platform According to the consultation of relevant enterprises, Jiangsu explicitly requires to fill in the prices of Guangdong and Chongqing drug exchanges When it comes to "price linkage" and "the lowest price in the country", drug recruiters are expected to be in a state of melancholy Today, different from the past, there are many non exclusive products competing manufacturers If they report high, they will lose their bid If they report low, there is no room for the market Don't ask about the policy, the company's high-level complains that the drug recruiters don't try their best; ask about the policy, the company's leaders turn around and complain about too many drug recruiters! Moreover, now the national price linkage is so terrible, it will be very troublesome once it is reported low Therefore, many enterprises like Fujian directly abandon the bid And the price of medicine is quietly falling, falling, and falling again